427962003: Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\UK product\Virtual therapeutic moiety\Nilotinib\Product containing only nilotinib in oral dose form (medicinal product form)\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\UK product\Virtual therapeutic moiety\Nilotinib\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing nilotinib\Nilotinib\Product containing only nilotinib in oral dose form (medicinal product form)\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing nilotinib\Nilotinib\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing nilotinib\Product containing nilotinib in oral dose form (medicinal product form)\Product containing only nilotinib in oral dose form (medicinal product form)\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing nilotinib\Nilotinib\Product containing only nilotinib in oral dose form (medicinal product form)\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing nilotinib\Nilotinib\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing nilotinib\Product containing nilotinib in oral dose form (medicinal product form)\Product containing only nilotinib in oral dose form (medicinal product form)\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing nilotinib\Nilotinib\Product containing only nilotinib in oral dose form (medicinal product form)\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing nilotinib\Nilotinib\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing nilotinib\Product containing nilotinib in oral dose form (medicinal product form)\Product containing only nilotinib in oral dose form (medicinal product form)\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule
\Medicinal product\Product manufactured as oral dose form\Product containing nilotinib in oral dose form (medicinal product form)\Product containing only nilotinib in oral dose form (medicinal product form)\Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

3681152013 Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT United Kingdom drug extension module

49350201000001110 Nilotinib 200mg capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Is a	Product containing nilotinib	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has active ingredient	Nilotinib	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has manufactured dose form	Capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has manufactured dose form	Conventional release oral capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Is a	Product manufactured as oral dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has active ingredient	Nilotinib hydrochloride monohydrate	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has active ingredient	Nilotinib hydrochloride monohydrate	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has basis of strength substance	Nilotinib	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has presentation strength numerator value	200	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has presentation strength denominator unit	Capsule	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has precise active ingredient	Nilotinib hydrochloride monohydrate	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has unit of presentation	Capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Is a	Product containing only nilotinib in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has unit of presentation	Capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has manufactured dose form	Conventional release oral capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	capsule.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has active ingredient	Nilotinib	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has manufactured dose form	Oral dose form	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has unit of presentation	Capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has manufactured dose form	Conventional release oral capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has manufactured dose form	Conventional release oral capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has unit of presentation	Capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Is a	Nilotinib	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has manufactured dose form	Capsule	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has active ingredient	Nilotinib hydrochloride monohydrate	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Nilotinib	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has specific active ingredient	Nilotinib hydrochloride monohydrate	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has dispensed dose form	Capsule	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has basis of strength substance	Nilotinib	false	Inferred relationship	Existential restriction modifier
Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Has manufactured dose form	Capsule	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Nilotinib 200mg capsules 112 capsule	Is pack of	False	Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Inferred relationship	Existential restriction modifier
Tasigna 200mg capsules (Novartis Pharmaceuticals UK Ltd)	Is a	True	Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Inferred relationship	Existential restriction modifier
Nilotinib 200mg capsules 112 capsule	Has VMP	True	Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3681152013	Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT United Kingdom drug extension module
49350201000001110	Nilotinib 200mg capsules	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module